Malignant tumor of prostate (disorder)

REQUITE

Year Started: 2013

Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

Access:
Access restricted at present
Type:
Disease specific
Status:
Completed
Collection point:
Pre-diagnosis
Consent restrictions:
No restrictions


Male

Adult (> 40 years)

1001 - 3000 donors

Material Type Preservation Type % of Sample Set Macroscopic Assessment
DNA -60 °C to -85 °C 100% Not applicable
Whole blood -60 °C to -85 °C 100% Not applicable